Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/75155
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ma, M. | - |
dc.contributor.author | Karas, J. | - |
dc.contributor.author | White, J. | - |
dc.contributor.author | Scanlon, D. | - |
dc.contributor.author | Donnelly, P. | - |
dc.date.issued | 2009 | - |
dc.identifier.citation | Chemical Communications, 2009; 14(22):3237-3239 | - |
dc.identifier.issn | 1359-7345 | - |
dc.identifier.issn | 1364-548X | - |
dc.identifier.uri | http://hdl.handle.net/2440/75155 | - |
dc.description.abstract | A new sarcophagine cage amine ligand with a pendent carboxylate functional group has been synthesised; the ligand has been conjugated to tumour targeting peptides ([Tyr3]- octreotate and [Lys3]-bombesin) and the conjugates radiolabelled with copper-64. | - |
dc.description.statementofresponsibility | Michelle T. Ma, John A. Karas, Jonathan M. White, Denis Scanlon and Paul S. Donnelly | - |
dc.language.iso | en | - |
dc.publisher | Royal Soc Chemistry | - |
dc.rights | © The Royal Society of Chemistry 2009 | - |
dc.source.uri | http://dx.doi.org/10.1039/b903426a | - |
dc.subject | Animals | - |
dc.subject | Humans | - |
dc.subject | Copper | - |
dc.subject | Amines | - |
dc.subject | Carboxylic Acids | - |
dc.subject | Peptides | - |
dc.subject | Chelating Agents | - |
dc.subject | Cross-Linking Reagents | - |
dc.subject | Radiopharmaceuticals | - |
dc.subject | Ligands | - |
dc.title | A new bifunctional chelator for copper radiopharmaceuticals: a cage amine ligand with a carboxylate functional group for conjugation to peptides | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1039/B903426A | - |
pubs.publication-status | Published | - |
Appears in Collections: | Aurora harvest Medical Sciences publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.